On the recordApril 11, 2018
There could have been significant cost reductions there if we did not have to wait for the years and years that it took to get the permitting process through.
Source
congress.govThere could have been significant cost reductions there if we did not have to wait for the years and years that it took to get the permitting process through.
Discussing delays in infrastructure projects due to permitting processes.
Share
More from Tom Marino
I look forward to hearing the witnesses' views on these issues and whether our existing antitrust laws are equipped to address these antitrust concerns in the FDA approval process.
This amendment makes three impactful changes to SITSA. First, it changes and sets strict definitions of what constitutes a controlled substance analogue suitable for inclusion in schedule A. A substance proposed for inclusion in schedule A…